Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Shareholders’ equity, Related Shareholder Matters and Issuer Purchases of Equity Securities.
Market
Information
Our
Units, Class A Ordinary Shares and Public Warrants are traded on Nasdaq under the symbols “IPAXU,” “IPAX” and
“IPAXW,” respectively.
Holders
As of April 6, 2022, there was one
holder of record of our Units, one holder of record of our Class A Ordinary Shares, one holder of record of our Class B ordinary
shares, one holder of record of our Public Warrants and one holder of record of our Private Placement Warrants.
Dividends
We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of an
Initial Business Combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial conditions subsequent to completion of an Initial Business Combination. The payment of any cash dividends
subsequent to an Initial Business Combination will be within the discretion of our board of directors at such time. If we incur any indebtedness,
our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.
Securities
Authorized for Issuance Under Equity Compensation Plans
None.
Recent
Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
In
February 2021, Inflection Point Holdings LLC, our Sponsor, paid $25,000, or approximately $0.003 per share, to cover certain of the Company’s
offering costs in exchange for 7,187,500 Founder Shares. Subsequently on March 5, 2021, we effected a 1.2 to 1 share recapitalization
with respect to our Class B ordinary shares, as a result of which our Sponsor then held 8,625,000 Founder Shares. On October 29, 2021,
as a result of the partial exercise of the over-allotment option, the Sponsor forfeited 381,250 of these Founder Shares and the remaining
Founder Shares are no longer subject to forfeiture.
The
Founder Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation
of the Company’s Initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that
additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the Company’s
Initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in
the aggregate, 20% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any
redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued,
or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the
Company in connection with or in relation to the consummation of the Initial Business Combination, excluding any Class A Ordinary
Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to
any seller in the Initial Business Combination and any Private Placement Warrants issued to the Sponsor, or the Company’s officers
or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than
one-for-one basis.
The
foregoing issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
On September 24, 2021, we consummated our Initial
Public Offering of 30,000,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $300,000,000.
Citigroup Global Markets Inc. acted as sole book-running manager. The underwriters had a 45-day option from the effective date of the
registration statement to purchase up to an additional 4,500,000 Units to cover over-allotments, if any. On October 29, 2021, the underwriters
partially exercised the over-allotment option and purchased an additional 2,975,000 Units, generating additional gross proceeds of $29,750,000,
and forfeited their option to purchase the remaining 1,525,000 Units. The securities sold in the offering were registered under the Securities
Act on registration statement on Form S-1 (No. 333- 253963). The SEC declared the registration statement effective on September 21, 2021.
47
Transaction costs amounted to $26,658,313, consisting
of $4,595,000 of underwriting commissions, $11,541,250 of deferred underwriting commissions, $9,680,125 of excess fair value of founder
shares, and $841,938 of other offering costs, with $23,439 included in the statement of operations as an allocation for the over-allotment
option, $24,538,134 included in temporary equity as an allocation for the Class A ordinary shares subject to redemption, and $2,096,740
included in additional paid-in capital as an allocation for the Class A ordinary shares not subject to redemption, the Public Warrants
and the Private Placement Warrants.
Simultaneously with the consummation of the Initial
Public Offering, we consummated the private placement of 6,250,000 Private Placement Warrants, at a price of $1.00 per Private Placement
Warrant, or $6,250,000 in the aggregate. On October 29, 2021, simultaneously with the sale of the Over-Allotment Units, the Sponsor purchased
an additional 595,000 Private Placement Warrants, generating aggregate gross proceeds to the Company of $595,000. Such securities were
issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are the same as
the Public Warrants sold as part of the Units sold in the Public Offering, except that the Private Placement Warrants are not transferable,
assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the Sponsor or its
permitted transferees.
Of the gross proceeds received from the Initial Public Offering and
Private Placement of Private Placement Warrants, $329,750,000 was placed in the Trust Account.
Item
6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.